COVID-19 updates, including vaccine information, for our patients and visitors Learn More
View All Releases >
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen re ...
Artificial intelligence-based technique reveals previously unknown cell components that may provide new clues to human development and disease.
UC San Diego researchers have produced a single-cell chromatin atlas for the human genome. Delineating chromatin regions in cells of different human tissue types would be a major step toward understan ...
A novel study — led by University of California San Diego and UCLA, in collaboration with the La Jolla Institute for Immunology — is assessing whether medicinal mushrooms and Chinese herbs provide the ...
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting an enzyme popular in oncological treatments.
View All Features >
The team at UC San Diego Health takes a family centered approach to treating children for burns that ensures the social, emotional and psychological needs are met for pediatric patients and their fami ...
María Madrigal, receptora de riñón donante, estaba plagada de bacterias multirresistentes; un tratamiento emergente llamado terapia con bacteriófagos resultó ser el remedio.
Donor kidney recipient Maria Madrigal was plagued by multidrug-resistant bacteria; an emerging treatment called phage therapy proved to be the remedy.
Convalescent therapy is a century-old approach adapted to potentially treating and preventing COVID-19 by boosting patients’ neutralizing antibodies. Edward Cachay, MD, leads a clinical trial at UC Sa ...
In the News
View More >
Features Atul Malhotra, MD
Features Rebecca Fielding-Miller, PhD, MSPH
Features UC San Diego Health
Features James Mangan, MD, PhD
Features Trey Ideker, PhD